BIOMAT Database Logo BIOMAT Database Logo

Linear IgA bullous dermatosis in a diabetic patient with chronic renal failure. 2002

Agnieszka Beata Serwin, and Hanna Myśliwiec, and Halina Laudańska, and Bozena Chodynicka
Department of Dermatology and Venereology, Medical Academy of Białystok, Białystok, Poland.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D003622 Dapsone A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) Diaminodiphenylsulfone,Sulfonyldianiline,4,4'-Diaminophenyl Sulfone,Avlosulfone,DADPS,Dapsoderm-X,Dapson-Fatol,Diaphenylsulfone,Disulone,Sulfona,4,4' Diaminophenyl Sulfone,Sulfone, 4,4'-Diaminophenyl
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents

Related Publications

Agnieszka Beata Serwin, and Hanna Myśliwiec, and Halina Laudańska, and Bozena Chodynicka
Linear IgA bullous dermatosis in a patient with chronic renal failure: response to intravenous immunoglobulin therapy.
March 1999, Journal of the American Academy of Dermatology,
Agnieszka Beata Serwin, and Hanna Myśliwiec, and Halina Laudańska, and Bozena Chodynicka
Linear IgA bullous dermatosis in a patient with renal cell carcinoma.
April 2001, The British journal of dermatology,
Agnieszka Beata Serwin, and Hanna Myśliwiec, and Halina Laudańska, and Bozena Chodynicka
Chronic bullous dermatosis of childhood. Linear iga bullous dermatosis.
March 1982, American journal of diseases of children (1960),
Agnieszka Beata Serwin, and Hanna Myśliwiec, and Halina Laudańska, and Bozena Chodynicka
[Chronic bullous dermatosis in childhood (linear IgA dermatosis)].
July 1993, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
Agnieszka Beata Serwin, and Hanna Myśliwiec, and Halina Laudańska, and Bozena Chodynicka
Linear IgA bullous dermatosis of childhood (chronic bullous dermatosis of childhood).
January 1991, Clinics in dermatology,
Agnieszka Beata Serwin, and Hanna Myśliwiec, and Halina Laudańska, and Bozena Chodynicka
Linear IgA bullous dermatosis in a patient with sclerosing cholangitis.
January 2002, Journal of the European Academy of Dermatology and Venereology : JEADV,
Agnieszka Beata Serwin, and Hanna Myśliwiec, and Halina Laudańska, and Bozena Chodynicka
Linear IgA Bullous Dermatosis.
June 2020, The New England journal of medicine,
Agnieszka Beata Serwin, and Hanna Myśliwiec, and Halina Laudańska, and Bozena Chodynicka
Linear IgA bullous dermatosis.
January 2001, Clinics in dermatology,
Agnieszka Beata Serwin, and Hanna Myśliwiec, and Halina Laudańska, and Bozena Chodynicka
Linear IgA bullous dermatosis.
November 1999, International journal of dermatology,
Agnieszka Beata Serwin, and Hanna Myśliwiec, and Halina Laudańska, and Bozena Chodynicka
Linear IgA Bullous Dermatosis.
January 2022, Journal of cutaneous medicine and surgery,
Copied contents to your clipboard!